PureTech launches new biotech built around lung disease drug
Written by
BioPharma Dive
Published
0
comments
0
min
The spinout, known as Celea Therapeutics, will advance what’s designed to be an improved version of the drug pirfenidone for idiopathic pulmonary fibrosis.